Dr. Peter Anthony Campochiaro, MD

Dr. Campochiaro practices at Jhu - Wilmer Eye Institute in Middle River, Maryland.

Dr. Campochiaro's NPI, 1598723850, was assigned on May 3, 2006. Dr. Campochiaro graduated from Johns Hopkins University School of Medicine in 1978. Dr. Campochiaro holds Maryland license D29624.

Dr. Campochiaro's primary practice is Jhu - Wilmer Eye Institute, at 6201 Greenleigh Ave, Middle River, MD 21220 in Baltimore County. The practice phone is (410) 614-5115.

Dr. Campochiaro's primary practice is Jhu - Wilmer Eye Institute in Middle River, Maryland. Dr. Campochiaro is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Campochiaro to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campochiaro practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Campochiaro's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Campochiaro is licensed in Maryland.

CMS data shows 5,416 Medicare services from Dr. Campochiaro across 6 procedure codes in 2024, for 277 Medicare patients. Medicare paid $533,753 for them. Every service was in an office.

CMS counts 277 Medicare patients who saw Dr. Campochiaro in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Campochiaro's median patient age at 71, with 62% women.

In 2024, Dr. Campochiaro wrote 68 Medicare Part D claims for 19 patients. 71% of them were for generic drugs. CMS names the drug for 61 of them, across 3 drugs with 11 or more claims each, at $2,086 in total drug cost. In 2023, CMS named 54 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Campochiaro for performance year 2024, reported as part of a group.

Dmand AI links 128 papers to Dr. Campochiaro, published from 1999 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors and Visual Acuity. Dr. Campochiaro has published most often in Ophthalmology. Dr. Campochiaro's most frequent co-authors are Raafay Sophie, MD, David S. Boyer, MD and Diana V. Do, MD.

Dmand AI links Dr. Campochiaro to 4 clinical trials. Conditions studied include Edema, Stargardt Disease and Wet Macular Degeneration. Johns Hopkins University sponsors the most, 4.

CMS Open Payments shows 164 general payments to Dr. Campochiaro from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Genentech, Inc. paid the most, $126,605. It also lists 31 research payments totaling $82,784 from 2017 to 2025.

Dr. Campochiaro graduated from Johns Hopkins University School of Medicine in 1978.